Issue 21, 2023

Background free in vivo29Si MR imaging with hyperpolarized PEGylated silicon nanoparticles

Abstract

This study demonstrated the potential of 50 nm PEGylated Si NPs for high-resolution in vivo29Si MR imaging, emphasizing their biocompatibility and water dispersibility. The acquisition of in vivo Si MR images using the lowest reported dose after subcutaneous and intraperitoneal administration opens new avenues for future 29Si MR studies.

Graphical abstract: Background free in vivo29Si MR imaging with hyperpolarized PEGylated silicon nanoparticles

Supplementary files

Article information

Article type
Communication
Submitted
15 اگست 2023
Accepted
22 ستمبر 2023
First published
22 ستمبر 2023

Analyst, 2023,148, 5355-5360

Background free in vivo29Si MR imaging with hyperpolarized PEGylated silicon nanoparticles

S. Yang, J. Kim, T. G. Lee, M. Park, H. Y. Son, C. G. Joo, J. H. Shim, Y. Lee and Y. Huh, Analyst, 2023, 148, 5355 DOI: 10.1039/D3AN01395B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements